KEA Announces Official Schedule for PG AYUSH Admission Tests

Published Date: 07 Mar 2023

Karnataka: The Karnataka Examinations Authority (KEA) has announced the Category Schedule for Document Verification for PG AYUSH Courses. details...

Read Full News

Latest News

Professional Corner: What’s New in Primary Care?

A new survey examines young adults’ use of primary care, Nebraska receives funding for rural training, and Trinity Health expands services in West Michigan.

Maternal BMI and Birth Length Tied to Dermatitis Risk

A higher maternal prepregnancy BMI and greater birth length are associated with an elevated risk for atopic dermatitis in offspring by 3 years of age, new research shows.

Diabetologists On the Rise as Disease Overwhelms Practices

The launch of the American College of Diabetology has helped dozens of physicians become board-certified, with more on the way.

CMA Funds Program to HELP International Physicians Practice

A new commitment will support a program that familiarizes internationally trained physicians with medical English and the Canadian healthcare system.

Doctors Fired After Unionizing Win Settlement From Employer

Peak Vista Community Health Centers will pay $1.2 million to four physicians and a nurse practitioner after a decision by the National Labor Relations Board.

Todays Updates

Evaluating Zeleciment Basivarsen in Myotonic Dystrophy Type 1: The Phase 3 HARMONIA Trial Isabella Ciccone, MPH

The phase 3 HARMONIA trial will evaluate whether a muscle- and CNS-targeted antisense conjugate improves function across multiple systems in patients with myotonic dystrophy type 1.

Zilucoplan Autoinjector Matches Bioequivalence of Pre-Filled Syringe in Myasthenia Gravis Marco Meglio

New data from the 2026 AANEM Annual Meeting showed zilucoplan delivered via autoinjector was bioequivalent to the pre-filled syringe and was well tolerated when self-administered by patients with generalized myasthenia gravis.

Global Phase 3 UPSTREAM MG Trial of Telitacicept Advances Enrollment in Generalized Myasthenia Gravis Isabella Ciccone, MPH

The ongoing phase 3 study is enrolling approximately 180 adults across more than 13 countries, with topline results expected in mid-2027.

EpilepsyGTx, Viralgen Partner on AAV Gene Therapy EPY201 Ahead of Planned First-in-Human Trial Louie Pasculli

EpilepsyGTx and Viralgen have entered a manufacturing collaboration to support development of EPY201, an investigational AAV9-based gene therapy for focal refractory epilepsy planned to enter first-in-human testing in 2027.

New Phase 3 Trials to Test Empasiprubart Against Placebo, IVIG in CIDP Louie Pasculli

Phase 3 trials EMNERGIZE and EMVIGORATE will evaluate the efficacy and safety of intravenous empasiprubart in adults with chronic inflammatory demyelinating polyradiculoneuropathy.

NeuroVoices: James Winkley, MD, on Analyzing Phase 3 PREVAIL Trial of Gefurulimab Marco Meglio

The chairman of the Neurology Service Line at Baptist Health in Kentucky discussed PREVIEW trial findings for gefelorilimab in generalized myasthenia gravis, including efficacy, safety, and what the subcutaneous C5 inhibitor could offer patients if approved.

Lessons From 10,000 Organ Transplants, With Ari Cohen, MD

Lessons From 10,000 Organ Transplants, With Ari Cohen, MD

Todays Updates

Evaluating Zeleciment Basivarsen in Myotonic Dystrophy Type 1: The Phase 3 HARMONIA Trial Isabella Ciccone, MPH

The phase 3 HARMONIA trial will evaluate whether a muscle- and CNS-targeted antisense conjugate improves function across multiple systems in patients with myotonic dystrophy type 1.

Zilucoplan Autoinjector Matches Bioequivalence of Pre-Filled Syringe in Myasthenia Gravis Marco Meglio

New data from the 2026 AANEM Annual Meeting showed zilucoplan delivered via autoinjector was bioequivalent to the pre-filled syringe and was well tolerated when self-administered by patients with generalized myasthenia gravis.

Global Phase 3 UPSTREAM MG Trial of Telitacicept Advances Enrollment in Generalized Myasthenia Gravis Isabella Ciccone, MPH

The ongoing phase 3 study is enrolling approximately 180 adults across more than 13 countries, with topline results expected in mid-2027.

EpilepsyGTx, Viralgen Partner on AAV Gene Therapy EPY201 Ahead of Planned First-in-Human Trial Louie Pasculli

EpilepsyGTx and Viralgen have entered a manufacturing collaboration to support development of EPY201, an investigational AAV9-based gene therapy for focal refractory epilepsy planned to enter first-in-human testing in 2027.

New Phase 3 Trials to Test Empasiprubart Against Placebo, IVIG in CIDP Louie Pasculli

Phase 3 trials EMNERGIZE and EMVIGORATE will evaluate the efficacy and safety of intravenous empasiprubart in adults with chronic inflammatory demyelinating polyradiculoneuropathy.

NeuroVoices: James Winkley, MD, on Analyzing Phase 3 PREVAIL Trial of Gefurulimab Marco Meglio

The chairman of the Neurology Service Line at Baptist Health in Kentucky discussed PREVIEW trial findings for gefelorilimab in generalized myasthenia gravis, including efficacy, safety, and what the subcutaneous C5 inhibitor could offer patients if approved.

Lessons From 10,000 Organ Transplants, With Ari Cohen, MD

Lessons From 10,000 Organ Transplants, With Ari Cohen, MD

Latest News

A new survey examines young adults’ use of primary care, Nebraska receives funding for rural training, and Trinity Health expands services in West Michigan.

A higher maternal prepregnancy BMI and greater birth length are associated with an elevated risk for atopic dermatitis in offspring by 3 years of age, new research shows.

The launch of the American College of Diabetology has helped dozens of physicians become board-certified, with more on the way.

A new commitment will support a program that familiarizes internationally trained physicians with medical English and the Canadian healthcare system.

Peak Vista Community Health Centers will pay $1.2 million to four physicians and a nurse practitioner after a decision by the National Labor Relations Board.

News All Time

The CDSCO panel approves AstraZeneca's study of the antihypertensive medication baxdrostat.

New Delhi: Under the Central Drug Standard Control, the Subject Expert Committee (SEC) has granted approval to AstraZeneca, a major pharmaceutical company.

Check the facts: Posts on social media asserting that biology is not necessary for NEET UG are false.

posts on social media asserting that biology coursework is no longer necessary for those aspiring to become doctors in order to take the National Eligibility-cum-Entrance Test.

Kerala High Court orders Time-Bound Immediate Investigation into Unnecessary Embarrassment of Doctors from Delayed Medical Negligence Probe.

New Delhi: The Kerala High Court on Monday highlighted the possibility that physicians who are innocent could be subjected to needless humiliation should the investigation delay.

Eugene A. Woods joins the board of directors at JnJ.

Johnson and Johnson has announced in New Brunswick that Eugene A. The new CEO of Advocate Health is Woods, MBA, MHA.

Only 30% of doctors' families who passed away from COVID-19 received compensation up until 2023:RTI.

In response to a Right to Information query asking about the total Covid martyrs compensated under the Pradhan Mantri Garib Kalyan Package (PMGKP),.

Medical students from Manipur who have been displaced are able to pursue their education via online or hybrid modes thanks to NMC.

The Undergraduate Medical Education Board (UGMEB) of the National Medical Commission (NMC) has permitted displaced parties, providing a remarkable reprieve.

Incorporate the Ankle Brachial Index examination to rule out peripheral artery disease: A CDSCO Panel Notifies Lupin Regarding Denosumab PK/PD Research.

New Delhi: Under the Central Drug Standard Control, the Subject Expert Committee (SEC) has approved the drug major Lupin.

Delhi High Court: MCI sanctions cannot be used as a yardstick for determining a doctor's shortcomings, flaws, or insufficiency.

New Delhi: The Delhi High Court recently declared that the punishment awarded by the MCI, which is now the National Medical Commission (NMC), could not be an.

As per JAMA, Prone Positioning Has No Effect on the Length of ECMO Weaning in Covid Patients with Severe ARDS.

According to Matthieu Schmidt and colleagues, a randomized clinical trial examined the effects of prone positioning on patients suffering from severe acute respiratory distress.

Rituximab and glucocorticoids in Wegener's Granulomatosis: A PMS Study Report approved by the CDSCO Panel.

New Delhi: The Central Drug Standard Control Organization (CDSCO)'s Subject Expert Committee (SEC) has authorized a post-marketing.

The manufacture and marketing of Azelnidipine and Metoprolol FDC tablets has been approved by the CDSCO Panel for Akum Pharmaceutical.

New Delhi: The Subject Expert Committee (SEC) operating under the Central Drug Standard has given the go-ahead to the pharmaceutical giant Akum Pharmaceuticals.

Health Bulletin / November 30, 2023.

Following a spike in respiratory cases, Uttarakhand and Karnataka are on alert due to a pneumonia outbreak in China. These are the top health stories of the day.

The MP government issues a directive to Yatharth Hospital to assume control of the Ramraja Hospital grounds.

MP: As a result of an order from the Commissionerate of Sagar Sambhag, Madhya, Yatharth Hospital experienced significant trouble yesterday.

Check Your Information: Media reports asserting that biology is not necessary for NEET UG are false.

New Delhi: Posts on social media assert that biology coursework is no longer necessary for applicants to the National Exam to pursue careers in medicine.

The deadline to submit course preferences, willingness to work, and fee for the special straw vacancy round for PG medical seats in Puducherry is today.

The Centralized Admission Committee (CENTAC) in Puducherry has released a notification concerning the special stray vacancy round for three open NEET PG seats.

A radiologist found guilty of violating the PC PNDT Act received a two-year rigorous prison sentence.

A session court in Jabalpur has found a DMRD doctor guilty of a heinous violation of the Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act.

Recommended News For You

Recent research suggests that vitamin supplements may increase the risk of developing cancer.

CAR-T Trial Raises Prospect of Preventing Myeloma in High-Risk Group

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

Durvalumab Wins FDA Approval in Limited-Stage SCLC

Germline Profiling May Improve Risk Stratification in t-MNs

New BCMA-Directed Therapies Show Promise in Multiple Myeloma

For older patients with Hodgkin lymphoma, novel regimens produce high response rates.

Recommended Articles For You

Vaccines that can help prevent cancer 

Genetic Screening: A Game Changer in Cancer Prevention 

Personalized Cancer Vaccines: The Next Frontier in Precision Oncology 

Uncovering the Subtle Signs of Prostate Cancer: Early Detection is Key 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

BMTs that are "half-matched" are effective in treating severe sickle cell disease.

2.

The FDA approves alexinib as an adjuvant treatment for non-small cell lung cancer.

3.

According to JAMA, women who have false-positive mammogram results are at a higher risk of developing breast cancer over time.

4.

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

5.

What Caused a Man to Develop Friable Bleeding Nodules on His Arms and Hips?

1.

Exploring the Benefits of Flexible Sigmoidoscopy: A Revolutionary Way to Detect Colorectal Cancer

2.

Therapeutic Advances in Tumor Calcium-Signaling Modulation

3.

Thyroidectomy & Survival: Highlights from ASCO 2025 and Current U.S. Findings

4.

Bone Marrow Regeneration in Hematologic Recovery

5.

HCC Codes in Oncology: Care Optimization in Plexiform Neurofibroma Management

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

1.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

2.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

3.

The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

4.

Evidence-Based Oncology

5.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot